DIONE DAPAGLIFLOZIN INVESTIGATION OF CARDIOVASCULAR OUTCOMES AND EVENTS

DEAD

Serial Number

85525586

Owner

BRISTOL-MYERS SQUIBB COMPANY

Attorney

Marilyn F. Kelly

Filing Date

Jan 26, 2012

Add to watchlist:

No watchlists yet

+ Create New Watchlist

DIONE DAPAGLIFLOZIN INVESTIGATION OF CARDIOVASCULAR OUTCOMES AND EVENTS Trademark

Serial Number: 85525586

DIONE DAPAGLIFLOZIN INVESTIGATION OF CARDIOVASCULAR OUTCOMES AND EVENTS is a trademark filed by BRISTOL-MYERS SQUIBB COMPANY on January 26, 2012. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Trademark Classes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Owner Contact Info

BRISTOL-MYERS SQUIBB COMPANY (4,814 trademarks)

NEW YORK, NY 10154

Entity Type: 03

Legal Representation

Attorney of Record

Marilyn F. Kelly

2,565 trademarks filed View all →

Trademark Details

Filing Date

January 26, 2012

Registration Date

Not Registered

Goods & Services

Medical and scientific research, namely, conducting clinical trials and clinical studies relating to pharmaceutical preparations for human use

Filing History

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND

Oct 4, 2012 MAB2

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

Oct 4, 2012 ABN2

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Mar 8, 2012 GNRN

NON-FINAL ACTION E-MAILED

Mar 8, 2012 GNRT

NON-FINAL ACTION WRITTEN

Mar 8, 2012 CNRT

ASSIGNED TO EXAMINER

Mar 1, 2012 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jan 30, 2012 NWOS

NEW APPLICATION ENTERED

Jan 30, 2012 NWAP

Related Trademarks

More from this Owner

EMPLICITI

EMPLICITI

EMPLICITI

APNUXO

APNUXO

YORJELPA

More in Same Class

ASSET - IMPACT OF INTRAVENOUS ABATACEPT ON SYNOVITIS, OSTEITIS AND STRUCTURAL DAMAGE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO METHOTREXATE: A RANDOMISED CONTROLLED TRIAL

ASSET - IMPACT OF INTRAVENOUS ABATACEPT ON SYNOVITIS, OSTEITIS AND STRUCTURAL DAMAGE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO METHOTREXATE: A RANDOMISED CONTROLLED TRIAL

Serial #85525639

ASCERTAIN - IMPACT OF INTRAVENOUS ABATACEPT ON SYNOVITIS, OSTEITIS AND STRUCTURAL DAMAGE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO METHOTREXATE: A RANDOMISED CONTROLLED TRIAL

ASCERTAIN - IMPACT OF INTRAVENOUS ABATACEPT ON SYNOVITIS, OSTEITIS AND STRUCTURAL DAMAGE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO METHOTREXATE: A RANDOMISED CONTROLLED TRIAL

GISDIRECT

I FIRST INSIGHT

RAMPLIFY TO AMPLIFY YOUR BUSINESS

RAMPLIFY TO AMPLIFY YOUR BUSINESS